These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 31718309)
1. Synthesis and screening of novel anthraquinone-quinazoline multitarget hybrids as promising anticancer candidates. Liang D; Su Z; Tian W; Li J; Li Z; Wang C; Li D; Hou H Future Med Chem; 2020 Jan; 12(2):111-126. PubMed ID: 31718309 [No Abstract] [Full Text] [Related]
2. Design, synthesis, biological evaluation and docking study of novel quinazoline derivatives as EGFR-TK inhibitors. Jin H; Wu BX; Zheng Q; Hu CH; Tang XZ; Zhang W; Rao GW Future Med Chem; 2021 Apr; 13(7):601-612. PubMed ID: 33685233 [No Abstract] [Full Text] [Related]
3. Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers. Wang C; Xu S; Peng L; Zhang B; Zhang H; Hu Y; Zheng P; Zhu W J Enzyme Inhib Med Chem; 2019 Dec; 34(1):203-217. PubMed ID: 30835140 [TBL] [Abstract][Full Text] [Related]
4. Molecular modelling and synthesis of quinazoline-based compounds as potential antiproliferative agents. Yassen AS; Elshihawy HE; Said MM; Abouzid KA Chem Pharm Bull (Tokyo); 2014; 62(5):454-66. PubMed ID: 24789927 [TBL] [Abstract][Full Text] [Related]
5. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses. Rezki N; Almehmadi MA; Ihmaid S; Shehata AM; Omar AM; Ahmed HEA; Aouad MR Bioorg Chem; 2020 Oct; 103():104133. PubMed ID: 32745759 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel quinazoline-derived EGFR/HER-2 dual-target inhibitors bearing a heterocyclic-containing tail as potential anti-tumor agents. Hao S; Wang JH; Hou L; Liang JW; Yan JH; Niu YF; Li XY; Sun Q; Meng FH Bioorg Chem; 2024 Oct; 151():107686. PubMed ID: 39111120 [TBL] [Abstract][Full Text] [Related]
7. Novel 2-[thio]acetamide linked quinazoline/1,2,4-triazole/chalcone hybrids: Design, synthesis, and anticancer activity as EGFR inhibitors and apoptotic inducers. Abdelkhalek AS; Kothayer H; Soltan MK; Ibrahim SM; Elbaramawi SS Arch Pharm (Weinheim); 2024 Jul; 357(7):e2300627. PubMed ID: 38593298 [TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents. Allam HA; Aly EE; Farouk AKBAW; El Kerdawy AM; Rashwan E; Abbass SES Bioorg Chem; 2020 May; 98():103726. PubMed ID: 32171987 [TBL] [Abstract][Full Text] [Related]
9. Novel 4-arylaminoquinazolines bearing Zhang Y; Chen L; Li X; Gao L; Hao Y; Li B; Yan Y J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1668-1677. PubMed ID: 31530043 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 2,4-disubstituted quinazoline derivatives targeting H1975 cells via EGFR-PI3K signaling pathway. Wang Z; Liu L; Dai H; Si X; Zhang L; Li E; Yang Z; Chao G; Zheng J; Ke Y; Lihong S; Zhang Q; Liu H Bioorg Med Chem; 2021 Aug; 43():116265. PubMed ID: 34192644 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of cinnamamide-quinazoline derivatives as potential EGFR inhibitors to reverse T790M mutation. Zhang B; Xu Z; Liu Q; Xia S; Liu Z; Liao Z; Gou S Bioorg Chem; 2021 Dec; 117():105420. PubMed ID: 34655841 [TBL] [Abstract][Full Text] [Related]
12. Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer. Choudhary S; Doshi A; Luckett-Chastain L; Ihnat M; Hamel E; Mooberry SL; Gangjee A Bioorg Med Chem; 2021 Apr; 35():116061. PubMed ID: 33647840 [TBL] [Abstract][Full Text] [Related]
13. Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors. Qin X; Lv Y; Liu P; Li Z; Hu L; Zeng C; Yang L Bioorg Med Chem Lett; 2016 Mar; 26(6):1571-1575. PubMed ID: 26879314 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of novel ErbB/HDAC multitargeted inhibitors with selectivity in EGFR Zhao L; Fan T; Shi Z; Ding C; Zhang C; Yuan Z; Sun Q; Tan C; Chu B; Jiang Y Eur J Med Chem; 2021 Mar; 213():113173. PubMed ID: 33493830 [TBL] [Abstract][Full Text] [Related]
15. Hybrid Quinazoline 1,3,5-Triazines as Epidermal Growth Factor Receptor (EGFR) Inhibitors with Anticancer Activity: Design, Synthesis, and Computational Study. Pathak P; Rimac H; Grishina M; Verma A; Potemkin V ChemMedChem; 2021 Mar; 16(5):822-838. PubMed ID: 33155373 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of 4-aniline quinazoline derivatives conjugated with hydrogen sulfide (H Zheng YG; Zhang WQ; Meng L; Wu XQ; Zhang L; An L; Li CL; Gao CY; Xu L; Liu Y Eur J Med Chem; 2020 Sep; 202():112522. PubMed ID: 32619886 [TBL] [Abstract][Full Text] [Related]
17. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro. Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702 [TBL] [Abstract][Full Text] [Related]
18. New 6-nitro-4-substituted quinazoline derivatives targeting epidermal growth factor receptor: design, synthesis and Farag AB; Othman AH; El-Ashrey MK; Abbas SE; Elwaie TA Future Med Chem; 2024; 16(19):2025-2041. PubMed ID: 39230501 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytotoxic evaluation, and molecular docking studies of novel quinazoline derivatives with benzenesulfonamide and anilide tails: Dual inhibitors of EGFR/HER2. Alkahtani HM; Abdalla AN; Obaidullah AJ; Alanazi MM; Almehizia AA; Alanazi MG; Ahmed AY; Alwassil OI; Darwish HW; Abdel-Aziz AA; El-Azab AS Bioorg Chem; 2020 Jan; 95():103461. PubMed ID: 31838290 [TBL] [Abstract][Full Text] [Related]
20. The combination of 4-anilinoquinazoline and cinnamic acid: a novel mode of binding to the epidermal growth factor receptor tyrosine kinase. Li DD; Lv PC; Zhang H; Zhang HJ; Hou YP; Liu K; Ye YH; Zhu HL Bioorg Med Chem; 2011 Aug; 19(16):5012-22. PubMed ID: 21763148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]